CIK: 1442443 - Address: 19820 North Creek Parkway, Suite 201, Bothell, WA 98011
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/24/16 13:10
5/20/16
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClendeninn Neil JamesWADM.d00.00131322D-76-51-614820-128-1081114-36-46
10/30/15 11:23
10/28/15
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClendeninn Neil JamesWADM.d142.69153720D-71-129-38-26-5-20-4-320-69-58-80
5/22/15 09:34
5/20/15
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClendeninn Neil JamesWADM.d00.00032115D-82-49-12-17-21-461-212483223-53
6/9/14 12:04
6/5/14
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClendeninn Neil JamesWADM.d00.00132612D-72-65-56-72-64-9-1531-5-3-11-35-25
5/28/13 12:25
5/23/13
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClendeninn Neil JamesWADM.d2110.64122610D-32-17-10-103363-1-4-12-14-25-64
10/19/12 15:01
10/18/12
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClendeninn Neil JamesWADM.d24.110178D-224814-50-3-1-2-6-10-14-10-25-46
8/7/12 18:27
8/3/12
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClendeninn Neil JamesWADM.d154.11141117D-325-4127-1230-1-4-14-15-32
7/6/11 12:50
7/1/11
OGXIOncogenex Pharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClendeninn Neil JamesA1DM.d133.8923New3D-203221080-11-1-3-22-46-30-15

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact